Skip to main content
Top
Gepubliceerd in: Quality of Life Research 10/2020

18-05-2020

Mapping the Minnesota Living with Heart Failure Questionnaire (MLHFQ) onto the Assessment of Quality of Life 8D (AQoL-8D) utility scores

Auteurs: Max Catchpool, Jay Ramchand, David L. Hare, Melissa Martyn, Ilias Goranitis

Gepubliceerd in: Quality of Life Research | Uitgave 10/2020

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

The Minnesota Living with Heart Failure Questionnaire (MLHFQ) is a widely used condition-specific measure of quality of life (QoL) in patients with heart failure. To use information from the MLHFQ in an economic evaluation, the MLHFQ must be mapped onto a preference-based measure of QoL. This study aims to develop a mapping algorithm between the MLHFQ and the Assessment of Quality of Life (AQoL) 8D utility instrument in patients with dilated cardiomyopathy (DCM).

Methods

MLHFQ and AQoL-8D data were collected on 61 Australian adults with idiopathic DCM or other non-hypertrophic cardiomyopathies. Three statistical methods were used as follows: ordinary least squares (OLS) regression, the robust MM estimator, and the generalised linear models (GLM). Each included a range of explanatory variables. Model performance was assessed using key goodness-of-fit measures, the mean absolute error (MAE), and the root-mean-square error (RMSE).

Results

The MLHFQ summary score and AQoL-8D utility scores were strongly correlated (r =  − 0.83, p < 0.0001) and the two subscales of the MLHFQ were correlated with the eight dimensions of the AQoL-8D. Utility scores were predicted with acceptable precision based on responses to the MLHFQ physical, emotional, social, and other subscales. OLS and GLM performed similarly with MAE and RMSE ranging 0.086–0.106 and 0.114–0.130, respectively.

Conclusion

The mapping algorithm developed in this study allows the derivation of AQoL-8D utilities from MLHFQ scores for use in cost-effectiveness analyses and most importantly, enables the economic evaluation of alternative heart failure therapy options when only the MLHFQ has been collected.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference Hershberger, R. E., Givertz, M. M., Ho, C. Y., Judge, D. P., Kantor, P. F., McBride, K. L., et al. (2018). Genetic evaluation of cardiomyopathy: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med, 20(9), 899–909.CrossRef Hershberger, R. E., Givertz, M. M., Ho, C. Y., Judge, D. P., Kantor, P. F., McBride, K. L., et al. (2018). Genetic evaluation of cardiomyopathy: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med, 20(9), 899–909.CrossRef
2.
go back to reference Maron, B. J., Towbin, J. A., Thiene, G., Antzelevitch, C., Corrado, D., Arnett, D., Moss, A. J., Seidman, C. E., Young, J. B., American Heart Association; Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; Council on Epidemiology and Prevention. (2006). Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; & Council on Epidemiology and Prevention. Circulation, 113(14), 1807–1816. Maron, B. J., Towbin, J. A., Thiene, G., Antzelevitch, C., Corrado, D., Arnett, D., Moss, A. J., Seidman, C. E., Young, J. B., American Heart Association; Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; Council on Epidemiology and Prevention. (2006). Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; & Council on Epidemiology and Prevention. Circulation, 113(14), 1807–1816.
3.
go back to reference Petretta, M., Pirozzi, F., Sasso, L., Paglia, A., & Bonaduce, D. (2011). Review and metaanalysis of the frequency of familial dilated cardiomyopathy. The American Journal of Cardiology, 108(8), 1171–1176.CrossRef Petretta, M., Pirozzi, F., Sasso, L., Paglia, A., & Bonaduce, D. (2011). Review and metaanalysis of the frequency of familial dilated cardiomyopathy. The American Journal of Cardiology, 108(8), 1171–1176.CrossRef
4.
go back to reference Gigli, M., Stolfo, D., Merlo, M., Barbati, G., Ramani, F., Brun, F., et al. (2017). Insights into mildly dilated cardiomyopathy: Temporal evolution and long-term prognosis. European Journal of Heart Failure, 19(4), 531–539.CrossRef Gigli, M., Stolfo, D., Merlo, M., Barbati, G., Ramani, F., Brun, F., et al. (2017). Insights into mildly dilated cardiomyopathy: Temporal evolution and long-term prognosis. European Journal of Heart Failure, 19(4), 531–539.CrossRef
5.
go back to reference Brazier, J., Ratcliffe, J., Saloman, J., & Tsuchiya, A. (2017). Measuring and valuing health benefits for economic evaluation. Oxford: Oxford University Press. Brazier, J., Ratcliffe, J., Saloman, J., & Tsuchiya, A. (2017). Measuring and valuing health benefits for economic evaluation. Oxford: Oxford University Press.
6.
go back to reference Riegel, B., Moser, D. K., Glaser, D., Carlson, B., Deaton, C., Armola, R., et al. (2002). The Minnesota Living With Heart Failure Questionnaire: sensitivity to differences and responsiveness to intervention intensity in a clinical population. Nursing Research, 51(4), 209–218.CrossRef Riegel, B., Moser, D. K., Glaser, D., Carlson, B., Deaton, C., Armola, R., et al. (2002). The Minnesota Living With Heart Failure Questionnaire: sensitivity to differences and responsiveness to intervention intensity in a clinical population. Nursing Research, 51(4), 209–218.CrossRef
7.
go back to reference Heo, S., Moser, D. K., Riegel, B., Hall, L. A., & Christman, N. (2005). Testing the psychometric properties of the Minnesota Living with Heart Failure questionnaire. Nursing Research, 54(4), 265–272.CrossRef Heo, S., Moser, D. K., Riegel, B., Hall, L. A., & Christman, N. (2005). Testing the psychometric properties of the Minnesota Living with Heart Failure questionnaire. Nursing Research, 54(4), 265–272.CrossRef
8.
go back to reference Rector, T. S., & Cohn, J. N. (1992). Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. American Heart Journal, 124(4), 1017–1025.CrossRef Rector, T. S., & Cohn, J. N. (1992). Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. American Heart Journal, 124(4), 1017–1025.CrossRef
9.
go back to reference Dakin, H., Abel, L., Burns, R., & Yang, Y. (2018). Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: An online database and application of the MAPS statement. Health and Quality of Life Outcomes, 16(1), 31.CrossRef Dakin, H., Abel, L., Burns, R., & Yang, Y. (2018). Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: An online database and application of the MAPS statement. Health and Quality of Life Outcomes, 16(1), 31.CrossRef
10.
go back to reference Gaff, C. L., Winship, I. M., Forrest, S. M., Hansen, D. P., Clark, J., Waring, P. M., et al. (2017). Preparing for genomic medicine: A real world demonstration of health system change. NPJ Genomic Medicine, 2(1), 16.CrossRef Gaff, C. L., Winship, I. M., Forrest, S. M., Hansen, D. P., Clark, J., Waring, P. M., et al. (2017). Preparing for genomic medicine: A real world demonstration of health system change. NPJ Genomic Medicine, 2(1), 16.CrossRef
11.
go back to reference Yang, Y., Muzny, D. M., Reid, J. G., Bainbridge, M. N., Willis, A., Ward, P. A., et al. (2013). Clinical whole-exome sequencing for the diagnosis of Mendelian disorders. New England Journal of Medicine, 369(16), 1502–1511.CrossRef Yang, Y., Muzny, D. M., Reid, J. G., Bainbridge, M. N., Willis, A., Ward, P. A., et al. (2013). Clinical whole-exome sequencing for the diagnosis of Mendelian disorders. New England Journal of Medicine, 369(16), 1502–1511.CrossRef
12.
go back to reference Ramchand, J., Wallis, M., Macciocca, I., Lynch, E., Farouque, O., Martyn, M., et al. (2020). Prospective evaluation of the utility of whole exome sequencing in dilated cardiomyopathy. Journal of American Heart Association, 9(2), e013346.CrossRef Ramchand, J., Wallis, M., Macciocca, I., Lynch, E., Farouque, O., Martyn, M., et al. (2020). Prospective evaluation of the utility of whole exome sequencing in dilated cardiomyopathy. Journal of American Heart Association, 9(2), e013346.CrossRef
13.
go back to reference Catchpool, M., Ramchand, J., Martyn, M., Hare, D. L., James, P. A., Trainer, A. H., et al. (2019). A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy. Genetic Medicine, 21(12), 2815–2822.CrossRef Catchpool, M., Ramchand, J., Martyn, M., Hare, D. L., James, P. A., Trainer, A. H., et al. (2019). A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy. Genetic Medicine, 21(12), 2815–2822.CrossRef
14.
go back to reference Munyombwe, T., Höfer, S., Fitzsimons, D., Thompson, D. R., Lane, D., Smith, K., et al. (2014). An evaluation of the Minnesota Living with Heart Failure Questionnaire using Rasch analysis. Quality of Life Research, 23(6), 1753–1765.CrossRef Munyombwe, T., Höfer, S., Fitzsimons, D., Thompson, D. R., Lane, D., Smith, K., et al. (2014). An evaluation of the Minnesota Living with Heart Failure Questionnaire using Rasch analysis. Quality of Life Research, 23(6), 1753–1765.CrossRef
15.
go back to reference Bilbao, A., Escobar, A., García-Perez, L., Navarro, G., & Quirós, R. (2016). The Minnesota living with heart failure questionnaire: Comparison of different factor structures. Health and Quality of Life Outcomes, 14(1), 23.CrossRef Bilbao, A., Escobar, A., García-Perez, L., Navarro, G., & Quirós, R. (2016). The Minnesota living with heart failure questionnaire: Comparison of different factor structures. Health and Quality of Life Outcomes, 14(1), 23.CrossRef
16.
go back to reference Richardson, J., Iezzi, A., Khan, M. A., & Maxwell, A. (2014). Validity and reliability of the Assessment of Quality of Life (AQoL)-8D multi-attribute utility instrument. The Patient-Patient-Centered Outcomes Research, 7(1), 85–96.CrossRef Richardson, J., Iezzi, A., Khan, M. A., & Maxwell, A. (2014). Validity and reliability of the Assessment of Quality of Life (AQoL)-8D multi-attribute utility instrument. The Patient-Patient-Centered Outcomes Research, 7(1), 85–96.CrossRef
17.
go back to reference Coelho, R., Ramos, S., Prata, J., Bettencourt, P., Ferreira, A., & Cerqueira-Gomes, M. (2005). Heart failure and health related quality of life. Clinical Practice and Epidemiology in Mental Health, 1(1), 19.CrossRef Coelho, R., Ramos, S., Prata, J., Bettencourt, P., Ferreira, A., & Cerqueira-Gomes, M. (2005). Heart failure and health related quality of life. Clinical Practice and Epidemiology in Mental Health, 1(1), 19.CrossRef
18.
go back to reference Payakachat, N., Ali, M. M., & Tilford, J. M. (2015). A systematic review. Pharmacoeconomics, 33(11), 1137–1154.CrossRef Payakachat, N., Ali, M. M., & Tilford, J. M. (2015). A systematic review. Pharmacoeconomics, 33(11), 1137–1154.CrossRef
19.
go back to reference Richardson, J., Khan, M. A., Chen, G., Iezzi, A., & Maxwell, A. (2012). Population norms and Australian profile using the Assessment of Quality of Life (AQoL) 8D utility instrument. Centre for Health Economics Research Paper. Richardson, J., Khan, M. A., Chen, G., Iezzi, A., & Maxwell, A. (2012). Population norms and Australian profile using the Assessment of Quality of Life (AQoL) 8D utility instrument. Centre for Health Economics Research Paper.
20.
go back to reference Gottlieb, S. S., Khatta, M., Friedmann, E., Einbinder, L., Katzen, S., Baker, B., et al. (2004). The influence of age, gender, and race on the prevalence of depression in heart failure patients. Journal of the American College of Cardiology, 43(9), 1542–1549.CrossRef Gottlieb, S. S., Khatta, M., Friedmann, E., Einbinder, L., Katzen, S., Baker, B., et al. (2004). The influence of age, gender, and race on the prevalence of depression in heart failure patients. Journal of the American College of Cardiology, 43(9), 1542–1549.CrossRef
21.
go back to reference Wailoo, A. J., Hernandez-Alava, M., Manca, A., Mejia, A., Ray, J., Crawford, B., et al. (2017). Mapping to estimate health-state utility from non-preference-based outcome measures: An ISPOR good practices for outcomes research task force report. Value in Health, 20(1), 18–27.CrossRef Wailoo, A. J., Hernandez-Alava, M., Manca, A., Mejia, A., Ray, J., Crawford, B., et al. (2017). Mapping to estimate health-state utility from non-preference-based outcome measures: An ISPOR good practices for outcomes research task force report. Value in Health, 20(1), 18–27.CrossRef
22.
go back to reference Rivero-Arias, O., Ouellet, M., Gray, A., Wolstenholme, J., Rothwell, P. M., & Luengo-Fernandez, R. (2010). Mapping the Modified Rankin Scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome. Medical Decision Making, 30(3), 341–354.CrossRef Rivero-Arias, O., Ouellet, M., Gray, A., Wolstenholme, J., Rothwell, P. M., & Luengo-Fernandez, R. (2010). Mapping the Modified Rankin Scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome. Medical Decision Making, 30(3), 341–354.CrossRef
23.
go back to reference Hutcheson, G. D. (2011). Ordinary least-squares regression. In L. Moutinho & G. D. Hutcheson (Eds.), The SAGE dictionary of quantitative management research (pp. 224–228). Thousand Oaks: SAGE Publications. Hutcheson, G. D. (2011). Ordinary least-squares regression. In L. Moutinho & G. D. Hutcheson (Eds.), The SAGE dictionary of quantitative management research (pp. 224–228). Thousand Oaks: SAGE Publications.
24.
go back to reference Ingles, J., Yeates, L., Hunt, L., McGaughran, J., Scuffham, P. A., Atherton, J., et al. (2013). Health status of cardiac genetic disease patients and their at-risk relatives. International Journal of Cardiology, 165(3), 448–453.CrossRef Ingles, J., Yeates, L., Hunt, L., McGaughran, J., Scuffham, P. A., Atherton, J., et al. (2013). Health status of cardiac genetic disease patients and their at-risk relatives. International Journal of Cardiology, 165(3), 448–453.CrossRef
25.
go back to reference Ingles, J., McGaughran, J., Scuffham, P. A., Atherton, J., & Semsarian, C. (2012). A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy. Heart, 98(8), 625–630.CrossRef Ingles, J., McGaughran, J., Scuffham, P. A., Atherton, J., & Semsarian, C. (2012). A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy. Heart, 98(8), 625–630.CrossRef
26.
go back to reference Kularatna, S., Byrnes, J., Chan, Y. K., Carrington, M. J., Stewart, S., & Scuffham, P. A. (2017). Comparison of contemporaneous responses for EQ-5D-3L and Minnesota Living with Heart Failure: A case for disease specific multiattribute utility instrument in cardiovascular conditions. International Journal of Cardiology, 227, 172–176.CrossRef Kularatna, S., Byrnes, J., Chan, Y. K., Carrington, M. J., Stewart, S., & Scuffham, P. A. (2017). Comparison of contemporaneous responses for EQ-5D-3L and Minnesota Living with Heart Failure: A case for disease specific multiattribute utility instrument in cardiovascular conditions. International Journal of Cardiology, 227, 172–176.CrossRef
27.
go back to reference Engel, L., Mortimer, D., Bryan, S., Lear, S. A., & Whitehurst, D. G. (2017). An investigation of the overlap between the ICECAP-A and five preference-based health-related quality of life instruments. PharmacoEconomics, 35(7), 741–753.CrossRef Engel, L., Mortimer, D., Bryan, S., Lear, S. A., & Whitehurst, D. G. (2017). An investigation of the overlap between the ICECAP-A and five preference-based health-related quality of life instruments. PharmacoEconomics, 35(7), 741–753.CrossRef
28.
go back to reference Kontodimopoulos, N., Aletras, V. H., Paliouras, D., & Niakas, D. (2009). Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments. Value in Health, 12(8), 1151–1157.CrossRef Kontodimopoulos, N., Aletras, V. H., Paliouras, D., & Niakas, D. (2009). Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments. Value in Health, 12(8), 1151–1157.CrossRef
29.
go back to reference Hollingworth, W., Campbell, J. D., Kowalski, J., Ravelo, A., Girod, I., Briggs, A., et al. (2010). Exploring the impact of changes in neurogenic urinary incontinence frequency and condition-specific quality of life on preference-based outcomes. Quality of Life Research, 19(3), 323–331.CrossRef Hollingworth, W., Campbell, J. D., Kowalski, J., Ravelo, A., Girod, I., Briggs, A., et al. (2010). Exploring the impact of changes in neurogenic urinary incontinence frequency and condition-specific quality of life on preference-based outcomes. Quality of Life Research, 19(3), 323–331.CrossRef
30.
go back to reference Mukuria, C., Rowen, D., Harnan, S., Rawdin, A., Wong, R., Ara, R., et al. (2019). An updated systematic review of studies mapping (or cross-walking) measures of health-related quality of life to generic preference-based measures to generate utility values. Applied Health Economics and Health Policy, 17(3), 295–313.CrossRef Mukuria, C., Rowen, D., Harnan, S., Rawdin, A., Wong, R., Ara, R., et al. (2019). An updated systematic review of studies mapping (or cross-walking) measures of health-related quality of life to generic preference-based measures to generate utility values. Applied Health Economics and Health Policy, 17(3), 295–313.CrossRef
31.
go back to reference Jiang, W., Alexander, J., Christopher, E., Kuchibhatla, M., Gaulden, L. H., Cuffe, M. S., et al. (2001). Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Archives of Internal Medicine, 161(15), 1849–1856.CrossRef Jiang, W., Alexander, J., Christopher, E., Kuchibhatla, M., Gaulden, L. H., Cuffe, M. S., et al. (2001). Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Archives of Internal Medicine, 161(15), 1849–1856.CrossRef
Metagegevens
Titel
Mapping the Minnesota Living with Heart Failure Questionnaire (MLHFQ) onto the Assessment of Quality of Life 8D (AQoL-8D) utility scores
Auteurs
Max Catchpool
Jay Ramchand
David L. Hare
Melissa Martyn
Ilias Goranitis
Publicatiedatum
18-05-2020
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 10/2020
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-020-02531-4

Andere artikelen Uitgave 10/2020

Quality of Life Research 10/2020 Naar de uitgave